HomeFounders News › Tools & AI
Tools & AI Global Sep 16, 2026

ByteDance-spun Anew Labs raises $290M for AI-driven drug discovery

Shanghai-based Anew Labs announced about $290M in inaugural external financing on September 16, 2026, from HSG, IDG Capital, Hillhouse, and 5Y Capital. Spun out of ByteDance, which retains a 56% stake, the company applies AI to drug discovery.

Why this matters for founders

Healthtech and biotech founders should watch AI-first drug discovery entrants as potential partners or competitors; the scale of this raise shows capital is flowing to AI applied in regulated science.

Source: Tech Startups

Related updates

More that helps you.

Get briefs like this tuned to you.

In the app, Founder Briefs are personalized to your country, industry and stage, and you can save the ones that matter.

See plans →
FoundersCheckList.AI app
Founders using FoundersCheckList.AI